NantHealth, Inc.
NHIQ
$0.05
$0.0494,900.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 14.29% | -42.85% | 52.30% | -87.89% | -9.15% |
| Total Depreciation and Amortization | 247.13% | -1.00% | -1.75% | -2.72% | 0.27% |
| Total Amortization of Deferred Charges | 35.80% | 15.19% | -38.00% | 4.11% | 5.18% |
| Total Other Non-Cash Items | -52.23% | 265.22% | -129.68% | 448.60% | -126.86% |
| Change in Net Operating Assets | -181.29% | -46.22% | 19.21% | -37.46% | 969.26% |
| Cash from Operations | -20.19% | 3.10% | 6.73% | -40.25% | 45.06% |
| Capital Expenditure | 101.36% | 35.87% | 45.44% | -78.76% | 21.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 101.36% | 35.87% | 45.44% | -78.76% | 21.89% |
| Total Debt Issued | -- | -100.00% | 104.55% | 563.85% | -- |
| Total Debt Repaid | -- | 100.00% | -1.27% | -1.47% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 68.26% | -- | -- | -- |
| Cash from Financing | 1,864.71% | -102.06% | 97.20% | 839.48% | -- |
| Foreign Exchange rate Adjustments | 58.33% | 1.06% | -1,089.47% | -70.99% | 509.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.26% | -164.37% | 1,002.31% | 122.14% | 53.15% |